These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24303008)

  • 41. Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake.
    Soria-Gómez E; Massa F; Bellocchio L; Rueda-Orozco PE; Ciofi P; Cota D; Oliet SH; Prospéro-García O; Marsicano G
    Neuroscience; 2014 Mar; 263():46-53. PubMed ID: 24434770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interaction between ghrelin and cannabinoid systems in penicillin-induced epileptiform activity in rats.
    Arslan G; Ayyildiz M; Agar E
    Neuropeptides; 2014 Dec; 48(6):345-52. PubMed ID: 25256087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
    Gomez O; Sanchez-Rodriguez A; Le M; Sanchez-Caro C; Molina-Holgado F; Molina-Holgado E
    Br J Pharmacol; 2011 Aug; 163(7):1520-32. PubMed ID: 21480865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats.
    Gessa GL; Orrù A; Lai P; Maccioni P; Lecca R; Lobina C; Carai MA; Colombo G
    Psychopharmacology (Berl); 2006 Apr; 185(2):248-54. PubMed ID: 16491428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exendin-4 decreases ghrelin levels through mTOR signaling.
    Hong X; Zhang H; Liang H; Li D; Huang J; Li Z; Jiang S; Zhang W; Xu G
    Mol Cell Endocrinol; 2016 Dec; 437():201-212. PubMed ID: 27569528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central cannabinoid signaling mediating food intake: a pharmacological-challenge magnetic resonance imaging and functional histology study in rat.
    Dodd GT; Stark JA; McKie S; Williams SR; Luckman SM
    Neuroscience; 2009 Nov; 163(4):1192-200. PubMed ID: 19607884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of mTOR signaling pathway proteins in rat gastric mucosa exposed to sulfite and ghrelin.
    Ercan S; Şahin P; Kencebay C; Derin N; Çelik Özenci Ç
    Turk J Gastroenterol; 2018 Jan; 29(1):94-100. PubMed ID: 29082888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner.
    Nishio S; Gibert Y; Berekelya L; Bernard L; Brunet F; Guillot E; Le Bail JC; Sánchez JA; Galzin AM; Triqueneaux G; Laudet V
    Mol Endocrinol; 2012 Aug; 26(8):1316-26. PubMed ID: 22700585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
    Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of rimonabant and other cannabinoid CB1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data.
    Carai MA; Colombo G; Maccioni P; Gessa GL
    CNS Drug Rev; 2006; 12(2):91-9. PubMed ID: 16958983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats.
    Cheer JF; Wassum KM; Wightman RM
    J Neurochem; 2006 May; 97(4):1145-54. PubMed ID: 16686693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. mTOR Pathway is Involved in Energy Homeostasis Regulation as a Part of the Gut-Brain Axis.
    Pena-Leon V; Perez-Lois R; Seoane LM
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.
    Bennetzen MF; Nielsen MP; Richelsen B; Pedersen SB
    Obesity (Silver Spring); 2008 Nov; 16(11):2451-5. PubMed ID: 18719671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.
    Tucci SA; Rogers EK; Korbonits M; Kirkham TC
    Br J Pharmacol; 2004 Nov; 143(5):520-3. PubMed ID: 15381634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.
    Delis F; Polissidis A; Poulia N; Justinova Z; Nomikos GG; Goldberg SR; Antoniou K
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):269-278. PubMed ID: 27994006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
    Järbe TU; DiPatrizio NV
    Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting Peripheral CB
    Godlewski G; Cinar R; Coffey NJ; Liu J; Jourdan T; Mukhopadhyay B; Chedester L; Liu Z; Osei-Hyiaman D; Iyer MR; Park JK; Smith RG; Iwakura H; Kunos G
    Cell Metab; 2019 Jun; 29(6):1320-1333.e8. PubMed ID: 31105045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.
    Martín-García E; Burokas A; Martín M; Berrendero F; Rubí B; Kiesselbach C; Heyne A; Gispert JD; Millán O; Maldonado R
    J Neurochem; 2010 Mar; 112(5):1338-13351. PubMed ID: 20028452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway.
    Huang NL; Juang JM; Wang YH; Hsueh CH; Liang YJ; Lin JL; Tsai CT; Lai LP
    Acta Pharmacol Sin; 2010 Nov; 31(11):1447-53. PubMed ID: 20953204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity.
    Jacobson LH; Commerford SR; Gerber SP; Chen YA; Dardik B; Chaperon F; Schwartzkopf C; Nguyen-Tran V; Hollenbeck T; McNamara P; He X; Liu H; Seidel HM; Jaton AL; Gromada J; Teixeira S
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):565-81. PubMed ID: 21947251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.